Indian biotech exec predicts a $10B industry boom

One of the leading figures in India's biotech industry says that the field is positioned to more than double in size over the next five years as more companies in the subcontinent tap in on the potential for opportunities in clinical trials, manufacturing and more. And she adds that India is well positioned to profit from the shift in R&D and trial work from Europe and the U.S. to Asia.

Read the full article at FierceBiotech